Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-03-23 | Mr. DeSchutter has been serving on the Board since January 2017. The Board has determined that Mr. DeSchutter’s many years of experience in senior management and board positions of publicly-traded companies, as well as his extensive insight and knowledge of the pharmaceutical industry and healthcare related issues qualify him to serve as a member of the Board and the committee on which he sits. |
Data sourced from SEC filings. Last updated: 2026-02-03